Prolactin levels, breast-feeding and milk production in a cohort of young healthy women from high-risk breast cancer families: Implications for breast cancer risk

Familial Cancer

Volumn 7, Issue 3, 2008, Pages 221-228

  Hietala, Maria ^a   Olsson, Håkan ^a   Jernström, Helena ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b MALMÖ UNIVERSITY   (Sweden)

Author keywords

BRCA1; BRCA2; Breast Cancer; Breast feeding; Milk production; Premenopausal Women; Prolactin Levels

Indexed keywords

BRCA1 ASSOCIATED RING DOMAIN PROTEIN 1; PROLACTIN;

ADULT; ANTHROPOMETRY; ARTICLE; BREAST CANCER; BREAST FEEDING; CANCER RISK; COHORT ANALYSIS; COUNSELING; FAMILY; FEMALE; GENE MUTATION; HIGH RISK POPULATION; HUMAN; LACTATION; LIFESTYLE; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; MENSTRUAL CYCLE; MILK PRODUCTION; NULLIPARA; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; QUESTIONNAIRE; REPRODUCTION;

ADULT; BRCA1 PROTEIN; BREAST FEEDING; BREAST NEOPLASMS; FEMALE; HUMANS; LACTATION; LOGISTIC MODELS; MIDDLE AGED; MUTATION; PILOT PROJECTS; PREMENOPAUSE; PROLACTIN; QUESTIONNAIRES; RISK ASSESSMENT;

EID: 48349115132     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10689-007-9178-0     Document Type: Article

References (47)

1. Cregan MD, Mitoulas LR, Hartmann PE (2002) Milk prolactin, feed volume and duration between feeds in women breastfeeding their full-term infants over a 24 h period. Exp Physiol 87(2):207-214
2. Henderson BR, Gerkins V, Rosario I, Casagrande J, Pike MC (1975) Elevated serum levels of estrogen and prolactin in daughters of patients with breast cancer. N Engl J Med 293(16):790-795
3. Eliassen AH, Tworoger SS, Hankinson SE (2007) Reproductive factors and family history of breast cancer in relation to plasma prolactin levels in premenopausal and postmenopausal women. Int J Cancer 120(7):1536-1541
4. Tworoger SS, Hankinson SE (2006) Prolactin and breast cancer risk. Cancer Lett 243(2):160-169
5. Tworoger SS, Sluss P, Hankinson SE (2006) Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women. Cancer Res 66(4):2476-2482
6. Musey VC, Collins DC, Musey PI, Martino-Saltzman D, Preedy JR (1987) Long-term effect of a first pregnancy on the secretion of prolactin. N Engl J Med 316(5):229-234
7. Yu MC, Gerkins VR, Henderson BE, Brown JB, Pike MC (1981) Elevated levels of prolactin in nulliparous women. Br J Cancer 43(6):826-831
8. Horseman ND (1999) Prolactin and mammary gland development. J Mammary Gland Biol Neoplasia 4(1):79-88
9. Narod SA, Foulkes WD (2004) BRCA1 and BRCA2: 1994 and beyond. Nat Rev Cancer 4(9):665-676
10. Razandi M, Pedram A, Rosen EM, Levin ER (2004) BRCA1 inhibits membrane estrogen and growth factor receptor signaling to cell proliferation in breast cancer. Mol Cell Biol 24(13):5900-5913
11. Cabanes A, Wang M, Olivo S et al (2004) Prepubertal estradiol and genistein exposures up-regulate BRCA1 mRNA and reduce mammary tumorigenesis. Carcinogenesis 25(5):741-748
12. Fan S, Wang J, Yuan R et al (1999) BRCA1 inhibition of estrogen receptor signaling in transfected cells. Science 284(5418):1354-1356
13. Rajan JV, Wang M, Marquis ST, Chodosh LA (1996) Brca2 is coordinately regulated with Brca1 during proliferation and differentiation in mammary epithelial cells. Proc Natl Acad Sci U S A 93(23):13078-13083
14. Rajan JV, Marquis ST, Gardner HP, Chodosh LA (1997) Developmental expression of Brca2 colocalizes with Brca1 and is associated with proliferation and differentiation in multiple tissues. Dev Biol 184(2):385-401
15. Marquis ST, Rajan JV, Wynshaw-Boris A et al (1995) The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues. Nat Genet 11(1):17-26
16. Russo J, Tay LK, Russo IH (1982) Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res Treat 2(1):5-73
17. Brown MA, Nicolai H, Howe K et al (2002) Expression of a truncated Brca1 protein delays lactational mammary development in transgenic mice. Transgenic Res 11(5):467-478
18. Cox DB, Owens RA, Hartmann PE (1996) Blood and milk prolactin and the rate of milk synthesis in women. Exp Physiol 81(6):1007-1020
19. Russo J, Lynch H, Russo IH (2001) Mammary gland architecture as a determining factor in the susceptibility of the human breast to cancer. Breast J 7(5):278-291
20. Jernström H, Johannsson O, Borg Å, Olsson H (1998) Do BRCA1 mutations affect the ability to breast-feed? Significantly shorter length of breast-feeding among BRCA1 mutation carriers compared with their unaffected relatives. Breast 7(6):320-324
21. Jernström H, Lubinski J, Lynch HT et al (2004) Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 96(14):1094-1098
22. Collaborative group on hormonal factors in breast cancer (2002) Breast cancer, breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet 360(9328):187-195
23. Gronwald J, Byrski T, Huzarski T et al (2006) Influence of selected lifestyle factors on breast and ovarian cancer risk in BRCA1 mutation carriers from Poland. Breast Cancer Res Treat 95(2):105-109
24. Andrieu N, Goldgar DE, Easton DF et al (2006) Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS). J Natl Cancer Inst 98(8):535-544
25. Scott JA, Binns CW, Graham KI, Oddy WH (2006) Temporal changes in the determinants of breastfeeding initiation. Birth 33(1):37-45
26. Tryggvadottir L, Olafsdottir EJ, Gudlaugsdottir S et al (2003) BRCA2 mutation carriers, reproductive factors and breast cancer risk. Breast Cancer Res 5(5):R121-R128
27. Jernström H, Knutsson M, Taskila P, Olsson H (1992) Plasma prolactin in relation to menstrual cycle phase, oral contraceptive use, arousal time and smoking habits. Contraception 46(6):543-548
28. Love RR, Rose DR, Surawicz TS, Newcomb PA (1991) Prolactin and growth hormone levels in premenopausal women with breast cancer and healthy women with a strong family history of breast cancer. Cancer 68(6):1401-1405
29. Tworoger SS, Eliassen AH, Rosner B, Sluss P, Hankinson SE (2004) Plasma prolactin concentrations and risk of postmenopausal breast cancer. Cancer Res 64(18):6814-6819
30. Cole EN, England PC, Sellwood RA, Griffiths K (1977) Serum prolactin concentrations throughout the menstrual cycle of normal women and patients with recent breast cancer. Eur J Cancer 13(7):677-684
31. Meyer F, Brown JB, Morrison AS, MacMahon B (1986) Endogenous sex hormones, prolactin, and breast cancer in premenopausal women. J Natl Cancer Inst 77(3):613-616
32. Easton DF, Ford D, Bishop DT (1995) Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet 56(1):265-271
33. Tonin P, Ghadirian P, Phelan C et al (1995) A large multisite cancer family is linked to BRCA2. J Med Genet 32(12):982-984
34. Antoniou A, Pharoah PD, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117-1130
35. Oldenburg RA, Meijers-Heijboer H, Cornelisse CJ, Devilee P (2007) Genetic susceptibility for breast cancer: how many more genes to be found? Crit Rev Oncol Hematol 63(2):125-149
36. Loman N, Bladstrom A, Johannsson O, Borg A, Olsson H (2003) Cancer incidence in relatives of a population-based set of cases of early-onset breast cancer with a known BRCA1 and BRCA2 mutation status. Breast Cancer Res 5(6):R175-R186
37. Vingraite J, Bartkeviciute R, Michaelsen KF (2004) A cohort study of term infants from Vilnius, Lithuania: feeding patterns. Acta Paediatr 93(10):1349-1355
38. Yang Q, Wen SW, Dubois L, Chen Y, Walker MC, Krewski D (2004) Determinants of breast-feeding and weaning in Alberta, Canada. J Obstet Gynaecol Can 26(11):975-981
39. Taveras EM, Capra AM, Braveman PA, Jensvold NG, Escobar GJ, Lieu TA (2003) Clinician support and psychosocial risk factors associated with breastfeeding discontinuation. Pediatrics 112(1 Pt 1):108-115
40. Michaelsen KF, Larsen PS, Thomsen BL, Samuelson G (1994) The Copenhagen cohort study on infant nutrition and growth: duration of breast feeding and influencing factors. Acta Paediatr 83(6):565-571
41. Lande B, Andersen LF, Baerug A et al (2003) Infant feeding practices and associated factors in the first six months of life: the Norwegian infant nutrition survey. Acta Paediatr 92(2):152-161
42. Berovic N (2003) Impact of sociodemographic features of mothers on breastfeeding in Croatia: questionnaire study. Croat Med J 44(5):596-600
43. Ekström A, Widström AM, Nissen E (2003) Duration of breastfeeding in Swedish primiparous and multiparous women. J Hum Lact 19(2):172-178
44. Amir LH, Donath SM (2003) Does maternal smoking have a negative physiological effect on breastfeeding? The epidemiological evidence. Breastfeed Rev 11(2):19-29
45. Scott JA, Binns CW, Oddy WH, Graham KI (2006) Predictors of breastfeeding duration: evidence from a cohort study. Pediatrics 117(4):e646-e655
46. Andersen AN, Ronn B, Tjonneland A, Djursing H, Schioler V (1984) Low maternal but normal fetal prolactin levels in cigarette smoking pregnant women. Acta Obstet Gynecol Scand 63(3):237-239
47. Freund C, Mirabel L, Annane K, Mathelin C (2005) [Breastfeeding and breast cancer]. Gynecol Obstet Fertil 33(10):739-744